Why the study?
Genetic variation is presumed to underlie sex differences in ischemic coronary heart disease events, prompting this search for sex-specific candidate genes associated with all-cause mortality in coronary artery disease.
Observational (n=684)
Answers are grounded in this paper and cite their sources.
This exploratory GWAS identified distinct, sex-specific candidate genes associated with all-cause mortality in patients with coronary artery disease, highlighting the potential role of sex-dimorphic genetic effects in CAD survival.
Ischemic coronary heart disease (IHD) is the leading cause of death worldwide. Genetic variation is presumed to be a major factor underlying sex differences for IHD events, including mortality. The purpose of this study was to identify sex-specific candidate genes associated with all-cause mortality among people diagnosed with coronary artery disease (CAD). We performed a sex-stratified, exploratory genome-wide association (GWAS) screen using existing data from CAD-diagnosed males (n = 510) and females (n = 174) who reported European ancestry from the Duke Catheterization Genetics biorepository. Extant genotype data for 785,945 autosomal SNPs generated with the Human Omni1-Quad BeadChip (Illumina, CA, USA) were analyzed using an additive inheritance model. We estimated instantaneous risk of all-cause mortality by genotype groups across the 11-year follow-up using Cox multivariate regression, covarying for age and genomic ancestry. The top GWAS hits associated with all-cause mortality among people with CAD included 8 SNPs among males and 15 among females (p = 1 × 10−6 or 10−7), adjusted for covariates. Cross-sex comparisons revealed distinct candidate genes. Biologically relevant candidates included rs9932462 (EMP2/TEKT5) and rs2835913 (KCNJ6) among males and rs7217169 (RAP1GAP2), rs8021816 (PRKD1), rs8133010 (PDE9A), and rs12145981 (LPGAT1) among females. We report 20 sex-specific candidate genes having suggestive association with all-cause mortality among CAD-diagnosed subjects. Findings demonstrate proof of principle for identifying sex-associated genetic factors that may help explain differential mortality risk in people with CAD. Replication and meta-analyses in larger studies with more diverse samples will strengthen future work in this area.
No takes yet. Share an insight, caveat, or question.
Dungan et al. (2022) conducted an observational in Coronary artery disease (CAD) (n=684). Sex-specific genetic variation (SNPs) vs. Different genotype groups and cross-sex comparisons was evaluated on All-cause mortality (p=1 × 10−6 or 10−7).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: